Sleep Related Neurogenic Tachypneas (SRNT) refers to a group of neurological disorders characterized by episodes of abnormally rapid breathing that occur during sleep. This condition typically affects individuals during their sleep cycles, specifically during rapid eye movement (REM) sleep. The term "sleep related" indicates that these tachypneas primarily manifest during sleep, although there can be some instances of occurrence while awake.
The abnormal rapid breathing, known as tachypnea, is caused by dysregulation in the central control of breathing. This dysregulation originates from the dysfunction or impairment of certain structures within the central nervous system (CNS), such as the medulla oblongata, that control respiratory functions. These abnormalities may result from genetic factors, neurological diseases, or other underlying conditions, which can vary among individuals.
Sleep Related Neurogenic Tachypneas can manifest in different forms, including but not limited to central sleep apnea (CSA), periodic breathing, and other related respiratory disorders. Symptoms may include frequent awakenings, excessive daytime sleepiness, snoring, gasping, and difficulty achieving restful, uninterrupted sleep. Diagnosis often involves polysomnography, a sleep study that monitors brain activity, breathing patterns, and other physiological parameters.
Treatment options depend on the underlying cause and severity of the SRNT. These may include the use of continuous positive airway pressure (CPAP) devices, medication, or in severe cases, more invasive interventions such as neurostimulation or surgical procedures.
Overall, Sleep Related Neurogenic Tachypneas encompass a range of disorders characterized by abnormal rapid breathing during sleep due to dysregulation in the central control of breathing, requiring proper diagnosis and management for improved sleep quality and overall well-being.